Evidence map›Paper›PMID 41260773›Full record

ReviewGastrointestinal endoscopy clinics of North America2026

Endoscopic Screening of Barrett's Esophagus.

Abdullah Alkhattabi, Arvind J Trindade, Prasad G Iyer

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Gastrointestinal endoscopy clinics of North America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abdullah AlkhattabiDivision of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA; Division of Gastroenterology and Hepatology, King Faisal Specialist Hospital Research Center, Jeddah, Saudi Arabia.
Arvind J TrindadeDivision of Gastroenterology, Rutgers University School of Medicine, New Brunswick, NJ, USA.
Prasad G IyerDivision of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA. Electronic address: Iyer.Prasad@mayo.edu.

Funding

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal AdenocarcinomaR01CA241164 · NCI · MAYO CLINIC ROCHESTER · PI Jagpreet Chhatwal, Prasad G. Iyer · 2019 to 2026
$3.9M
NCI NIH HHS R01 CA241164
6 · The paper itself

Abstract

Endoscopic Barrett's esophagus (BE) screening detects premalignant changes, enabling the detection of BE and endoscopic surveillance to detect dysplasia/esophageal adenocarcinoma (EAC). Endoscopic therapy for BE dysplasia reduces EAC risk and can treat early stage EAC effectively. Screening is advised for those with multiple risk factors: chronic reflux, age over 50 years, male sex, Caucasian race, smoking, central obesity, hiatal hernia, or family history. Risk prediction tools are evolving. High-definition endoscopy with biopsies enables detection; precise landmark identification is key.

Indexed as

AdenocarcinomaBarrett EsophagusEarly Detection of CancerEsophageal NeoplasmsEsophagoscopyPrecancerous ConditionsBiopsyHumansRisk FactorsBarrett’s esophagusBarrett’s esophagus risk factorsEndoscopic screeningGastroesophageal reflux diseaseScreening

Identifiers

PMID41260773
PMCPMC13247874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.